 Amy Huebschmann
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 17 | 2023 | 2098 | 2.120 |
Why?
| | Exercise | 13 | 2022 | 1644 | 1.950 |
Why?
| | Contraception | 2 | 2021 | 117 | 1.100 |
Why?
| | Diabetes Mellitus | 5 | 2020 | 906 | 0.900 |
Why?
| | Telemedicine | 2 | 2021 | 665 | 0.830 |
Why?
| | Motivation | 2 | 2018 | 498 | 0.830 |
Why?
| | Cardiovascular Diseases | 5 | 2023 | 1729 | 0.820 |
Why?
| | Self-Management | 2 | 2019 | 126 | 0.730 |
Why?
| | Mentoring | 1 | 2022 | 101 | 0.700 |
Why?
| | Counseling | 2 | 2014 | 342 | 0.700 |
Why?
| | Research Design | 4 | 2022 | 930 | 0.700 |
Why?
| | Couples Therapy | 1 | 2019 | 13 | 0.680 |
Why?
| | Postpartum Period | 1 | 2021 | 278 | 0.630 |
Why?
| | Primary Health Care | 10 | 2023 | 1512 | 0.630 |
Why?
| | Information Dissemination | 2 | 2023 | 188 | 0.600 |
Why?
| | Reproducibility of Results | 2 | 2022 | 2799 | 0.510 |
Why?
| | Hair | 1 | 2015 | 65 | 0.500 |
Why?
| | Athletes | 1 | 2018 | 324 | 0.490 |
Why?
| | Health Behavior | 3 | 2020 | 704 | 0.490 |
Why?
| | Patients | 3 | 2020 | 162 | 0.470 |
Why?
| | Humans | 53 | 2023 | 115049 | 0.470 |
Why?
| | Health Promotion | 3 | 2021 | 686 | 0.440 |
Why?
| | Hypertension | 4 | 2022 | 1058 | 0.430 |
Why?
| | Professional-Patient Relations | 2 | 2012 | 140 | 0.430 |
Why?
| | Biomedical Research | 1 | 2019 | 585 | 0.430 |
Why?
| | Delivery of Health Care | 5 | 2022 | 835 | 0.420 |
Why?
| | Healthcare Disparities | 1 | 2018 | 480 | 0.410 |
Why?
| | Surveys and Questionnaires | 9 | 2021 | 4631 | 0.390 |
Why?
| | Aging, Premature | 1 | 2011 | 11 | 0.390 |
Why?
| | Critical Pathways | 1 | 2012 | 74 | 0.380 |
Why?
| | Caregivers | 4 | 2023 | 712 | 0.360 |
Why?
| | Aged | 16 | 2023 | 19122 | 0.350 |
Why?
| | Feasibility Studies | 3 | 2022 | 746 | 0.340 |
Why?
| | Dietary Fats | 1 | 2012 | 290 | 0.340 |
Why?
| | Medicare | 4 | 2022 | 666 | 0.330 |
Why?
| | Occupational Health | 2 | 2022 | 164 | 0.330 |
Why?
| | Asthma | 1 | 2022 | 2051 | 0.330 |
Why?
| | Social Determinants of Health | 3 | 2020 | 136 | 0.330 |
Why?
| | Disease Management | 2 | 2015 | 563 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1178 | 0.320 |
Why?
| | Fear | 1 | 2011 | 292 | 0.310 |
Why?
| | Physical Exertion | 1 | 2009 | 211 | 0.310 |
Why?
| | Diabetic Angiopathies | 3 | 2017 | 244 | 0.300 |
Why?
| | Middle Aged | 18 | 2020 | 26830 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2014 | 1184 | 0.290 |
Why?
| | Perception | 1 | 2009 | 310 | 0.280 |
Why?
| | Adult | 19 | 2021 | 30658 | 0.280 |
Why?
| | Attitude of Health Personnel | 1 | 2014 | 976 | 0.280 |
Why?
| | Female | 25 | 2023 | 59617 | 0.280 |
Why?
| | Qualitative Research | 4 | 2023 | 935 | 0.270 |
Why?
| | Sex Factors | 3 | 2019 | 1721 | 0.270 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 57 | 0.260 |
Why?
| | Physicians | 3 | 2023 | 772 | 0.260 |
Why?
| | Vascular Stiffness | 2 | 2023 | 408 | 0.260 |
Why?
| | Point-of-Care Systems | 2 | 2020 | 139 | 0.240 |
Why?
| | Mass Screening | 3 | 2021 | 1012 | 0.240 |
Why?
| | Social Support | 2 | 2019 | 528 | 0.230 |
Why?
| | Cross-Sectional Studies | 8 | 2021 | 4411 | 0.220 |
Why?
| | Oxygen | 2 | 2018 | 854 | 0.210 |
Why?
| | Chronic Disease | 3 | 2022 | 1591 | 0.210 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2023 | 69 | 0.200 |
Why?
| | Adolescent | 9 | 2022 | 17864 | 0.200 |
Why?
| | Leg | 2 | 2021 | 227 | 0.200 |
Why?
| | Heart Failure | 3 | 2023 | 1962 | 0.190 |
Why?
| | Male | 20 | 2023 | 55735 | 0.190 |
Why?
| | United States | 10 | 2022 | 12227 | 0.190 |
Why?
| | Health Equity | 1 | 2022 | 53 | 0.190 |
Why?
| | Government Programs | 1 | 2021 | 22 | 0.190 |
Why?
| | Oxygen Consumption | 6 | 2021 | 588 | 0.190 |
Why?
| | Health Care Surveys | 2 | 2014 | 538 | 0.190 |
Why?
| | Decision Support Systems, Clinical | 1 | 2023 | 177 | 0.180 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 156 | 0.180 |
Why?
| | Dementia | 1 | 2023 | 186 | 0.180 |
Why?
| | Contraceptive Agents | 1 | 2021 | 54 | 0.180 |
Why?
| | Patient Navigation | 1 | 2022 | 64 | 0.180 |
Why?
| | Home Care Services | 1 | 2023 | 222 | 0.180 |
Why?
| | Guatemala | 1 | 2021 | 266 | 0.180 |
Why?
| | Multiple Chronic Conditions | 1 | 2020 | 24 | 0.180 |
Why?
| | Palliative Care | 2 | 2023 | 639 | 0.180 |
Why?
| | Intimate Partner Violence | 1 | 2021 | 59 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2015 | 1081 | 0.170 |
Why?
| | Social Welfare | 1 | 2019 | 20 | 0.170 |
Why?
| | Patient Preference | 1 | 2022 | 169 | 0.170 |
Why?
| | Social Work | 1 | 2020 | 74 | 0.170 |
Why?
| | Community Mental Health Services | 1 | 2020 | 84 | 0.170 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 12 | 0.170 |
Why?
| | Patient Care Planning | 1 | 2020 | 139 | 0.170 |
Why?
| | Patient Care Team | 2 | 2022 | 515 | 0.170 |
Why?
| | Inpatients | 1 | 2023 | 378 | 0.170 |
Why?
| | Sitagliptin Phosphate | 1 | 2019 | 30 | 0.160 |
Why?
| | Accelerometry | 1 | 2019 | 73 | 0.160 |
Why?
| | Interviews as Topic | 2 | 2019 | 584 | 0.160 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 35 | 0.160 |
Why?
| | Schools | 1 | 2022 | 400 | 0.160 |
Why?
| | Diastole | 1 | 2019 | 131 | 0.160 |
Why?
| | Focus Groups | 2 | 2023 | 385 | 0.160 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 43 | 0.160 |
Why?
| | Exercise Tolerance | 2 | 2017 | 213 | 0.160 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1006 | 0.160 |
Why?
| | Cardiovascular System | 1 | 2019 | 126 | 0.150 |
Why?
| | Cultural Characteristics | 1 | 2018 | 59 | 0.150 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2017 | 48 | 0.150 |
Why?
| | Checklist | 1 | 2018 | 84 | 0.150 |
Why?
| | Ultrasonography | 1 | 2020 | 636 | 0.140 |
Why?
| | Patient Satisfaction | 2 | 2019 | 580 | 0.140 |
Why?
| | Health Care Costs | 1 | 2020 | 381 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 93 | 0.140 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1477 | 0.140 |
Why?
| | Pilot Projects | 2 | 2019 | 1375 | 0.140 |
Why?
| | Research Personnel | 1 | 2018 | 151 | 0.140 |
Why?
| | Microvessels | 1 | 2017 | 68 | 0.140 |
Why?
| | Venoms | 1 | 2016 | 30 | 0.140 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2016 | 34 | 0.140 |
Why?
| | Self Efficacy | 1 | 2019 | 355 | 0.130 |
Why?
| | Sex Characteristics | 2 | 2022 | 635 | 0.130 |
Why?
| | Lung Diseases | 1 | 2022 | 703 | 0.130 |
Why?
| | Quality Improvement | 1 | 2023 | 953 | 0.130 |
Why?
| | Blood Vessels | 1 | 2017 | 180 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2021 | 765 | 0.120 |
Why?
| | Risk Factors | 3 | 2020 | 8642 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 679 | 0.120 |
Why?
| | American Heart Association | 1 | 2015 | 264 | 0.120 |
Why?
| | Prospective Studies | 3 | 2021 | 6232 | 0.110 |
Why?
| | Prevalence | 1 | 2019 | 2255 | 0.110 |
Why?
| | Incidence | 1 | 2019 | 2318 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1322 | 0.110 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2016 | 361 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2019 | 799 | 0.110 |
Why?
| | Faculty | 1 | 2014 | 130 | 0.110 |
Why?
| | Interprofessional Relations | 1 | 2015 | 251 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2015 | 383 | 0.100 |
Why?
| | Pharmacists | 1 | 2015 | 236 | 0.100 |
Why?
| | Attitude to Health | 1 | 2015 | 405 | 0.100 |
Why?
| | Internal Medicine | 1 | 2014 | 211 | 0.100 |
Why?
| | Women's Health | 1 | 2014 | 271 | 0.100 |
Why?
| | Peptides | 1 | 2016 | 849 | 0.090 |
Why?
| | Exercise Test | 2 | 2015 | 545 | 0.090 |
Why?
| | Psychotherapy | 1 | 2012 | 149 | 0.090 |
Why?
| | Dietary Carbohydrates | 1 | 2012 | 136 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2012 | 195 | 0.090 |
Why?
| | Plant Preparations | 1 | 2010 | 23 | 0.090 |
Why?
| | Health Expenditures | 1 | 2012 | 171 | 0.090 |
Why?
| | Obesity | 2 | 2023 | 2524 | 0.090 |
Why?
| | Workplace | 2 | 2022 | 220 | 0.090 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 208 | 0.080 |
Why?
| | Depressive Disorder | 1 | 2012 | 333 | 0.080 |
Why?
| | Nonprescription Drugs | 1 | 2010 | 68 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 682 | 0.080 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 130 | 0.080 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 430 | 0.080 |
Why?
| | Patient Compliance | 1 | 2012 | 524 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 1857 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2012 | 492 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2016 | 4420 | 0.070 |
Why?
| | Prejudice | 1 | 2007 | 56 | 0.070 |
Why?
| | Walking | 1 | 2011 | 424 | 0.070 |
Why?
| | Colorado | 2 | 2014 | 4089 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2011 | 281 | 0.070 |
Why?
| | Disclosure | 1 | 2007 | 101 | 0.070 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2006 | 29 | 0.070 |
Why?
| | Hypoglycemia | 1 | 2010 | 385 | 0.060 |
Why?
| | Medicaid | 2 | 2019 | 409 | 0.060 |
Why?
| | Mental Health | 2 | 2022 | 559 | 0.060 |
Why?
| | Mothers | 1 | 2011 | 652 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 201 | 0.060 |
Why?
| | Child | 6 | 2022 | 18407 | 0.060 |
Why?
| | Age Factors | 1 | 2012 | 2894 | 0.060 |
Why?
| | Internship and Residency | 1 | 2014 | 941 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2017 | 428 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2019 | 1665 | 0.060 |
Why?
| | Patient Care | 1 | 2023 | 103 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1624 | 0.050 |
Why?
| | Longevity | 1 | 2022 | 137 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 257 | 0.050 |
Why?
| | Point-of-Care Testing | 1 | 2020 | 29 | 0.050 |
Why?
| | Small Business | 1 | 2021 | 51 | 0.050 |
Why?
| | Stroke Volume | 1 | 2023 | 510 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 10498 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 474 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2019 | 1812 | 0.040 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 44 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1636 | 0.040 |
Why?
| | Self Care | 1 | 2022 | 351 | 0.040 |
Why?
| | Goals | 1 | 2020 | 152 | 0.040 |
Why?
| | Consensus | 1 | 2021 | 534 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 198 | 0.040 |
Why?
| | Poverty | 1 | 2022 | 443 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2012 | 9123 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 481 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 74 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 94 | 0.040 |
Why?
| | Capillary Resistance | 1 | 2017 | 5 | 0.040 |
Why?
| | Oxyhemoglobins | 1 | 2017 | 20 | 0.040 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2017 | 47 | 0.040 |
Why?
| | Publishing | 1 | 2018 | 125 | 0.030 |
Why?
| | Microcirculation | 1 | 2017 | 135 | 0.030 |
Why?
| | Bicycling | 1 | 2017 | 84 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 722 | 0.030 |
Why?
| | Communication | 1 | 2022 | 744 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2017 | 337 | 0.030 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2016 | 100 | 0.030 |
Why?
| | Hemoglobins | 1 | 2017 | 315 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1215 | 0.030 |
Why?
| | Blood Pressure | 1 | 2021 | 1539 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1085 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2389 | 0.030 |
Why?
| | Ventricular Function | 1 | 2015 | 56 | 0.030 |
Why?
| | Arteries | 1 | 2016 | 249 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 351 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 92 | 0.030 |
Why?
| | Forearm | 1 | 2015 | 114 | 0.030 |
Why?
| | Endothelium | 1 | 2015 | 112 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2015 | 197 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 178 | 0.030 |
Why?
| | Reaction Time | 1 | 2015 | 375 | 0.030 |
Why?
| | Pediatrics | 1 | 2020 | 981 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2359 | 0.030 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 40 | 0.030 |
Why?
| | Vasodilation | 1 | 2015 | 417 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2016 | 714 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1558 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 2976 | 0.020 |
Why?
| | Mexico | 1 | 2011 | 162 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2015 | 633 | 0.020 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 850 | 0.020 |
Why?
| | Blood Glucose | 1 | 2019 | 1821 | 0.020 |
Why?
| | Emigrants and Immigrants | 1 | 2011 | 107 | 0.020 |
Why?
| | Mental Health Services | 1 | 2012 | 321 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1457 | 0.020 |
Why?
| | Homosexuality, Female | 1 | 2007 | 25 | 0.020 |
Why?
| | Logistic Models | 1 | 2012 | 1839 | 0.020 |
Why?
| | Models, Statistical | 1 | 2011 | 602 | 0.020 |
Why?
| | Public Opinion | 1 | 2007 | 59 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 623 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1077 | 0.020 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 608 | 0.020 |
Why?
| | Homosexuality, Male | 1 | 2007 | 170 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2012 | 12548 | 0.020 |
Why?
| | Health Personnel | 1 | 2007 | 574 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 6357 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 5520 | 0.010 |
Why?
| | Infant | 1 | 2010 | 7946 | 0.010 |
Why?
| | Child, Preschool | 1 | 2010 | 9093 | 0.010 |
Why?
|
|
Huebschmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|